Company Profile
Kezar Life Sciences Stock Price, News & Analysis
- Ticker:
- KZR
- Exchange:
- NASDAQ
- Sector:
- Life Science Tools
- Location:
- United States
Stock performance
7.29 USD (-0.95%)
Close
Last updated: May 8, 2026
53.9M USD
Market cap
Why the stock is moving
Current closing-price context is not available for KZR.
Company overview
Business overview
Kezar Life Sciences is a biotechnology company focused on immune pathways in autoimmune disease and oncology. Its strategy has centered on selective small-molecule biology and translational proof.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Kezar sits in specialty biotechnology.
Business Model Characteristics
The business depends on clinical data, target validation, and the possibility of building a differentiated immune-modulation platform.
Position Within the Biotechnology Landscape
Kezar is a catalyst-sensitive immunology name whose stock is driven by proof-of-concept and strategic updates.
Future catalysts
Kezar’s catalysts are zetomipzomib and the remaining immunology pipeline, where the next update matters because the market needs a clearer read on what still has value. The company is in a reset phase, so strategic clarity matters as much as data.
Recent news
- 01
Kezar Announces Pricing of a Public Offering of $46.7 million of Common Stock and Pre-Funded Warrants
Source: Kezar Life Sciences
- 02
Kezar Announces Proposed Public Offering of Common Stock
Source: Kezar Life Sciences
- 03
Kezar Provides Data Update from MISSION Study of KZR-616
Source: Kezar Life Sciences
- 04
Kezar Life Sciences to Participate in Fireside Chat During the Jefferies Virtual Healthcare Conference
Source: Kezar Life Sciences
- 05
Kezar Announces Presentations During Upcoming Scientific Conferences
Source: Kezar Life Sciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Kezar Life Sciences (KZR)?
Kezar Life Sciences (KZR) most recently closed at 7.29 USD, a -0.95% move versus the previous session.
What is the market cap of Kezar Life Sciences (KZR)?
Kezar Life Sciences currently has a market capitalization of 53.9M USD on BioPharmSignal.
What does Kezar Life Sciences do?
Kezar Life Sciences is a biotechnology company focused on immune pathways in autoimmune disease and oncology. Its strategy has centered on selective small-molecule biology and translational proof.
On which exchange is KZR stock listed?
Kezar Life Sciences (KZR) is associated with NASDAQ, United States, Life Science Tools.
What is Kezar?
Kezar’s catalysts are zetomipzomib and the remaining immunology pipeline, where the next update matters because the market needs a clearer read on what still has value.
Which conditions is Kezar Life Sciences targeting with Kezar?
Kezar Life Sciences is associated with oncology, immunology based on its company overview and current catalyst commentary.
How does Kezar Life Sciences describe recent progress with Kezar?
Kezar’s catalysts are zetomipzomib and the remaining immunology pipeline, where the next update matters because the market needs a clearer read on what still has value.
What is Life?
Kezar Life Sciences is a biotechnology company focused on immune pathways in autoimmune disease and oncology.